BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25572390)

  • 1. Correlating structural and energetic changes in glycine receptor activation.
    Scott S; Lynch JW; Keramidas A
    J Biol Chem; 2015 Feb; 290(9):5621-34. PubMed ID: 25572390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β Subunit M2-M3 loop conformational changes are uncoupled from α1 β glycine receptor channel gating: implications for human hereditary hyperekplexia.
    Shan Q; Han L; Lynch JW
    PLoS One; 2011; 6(11):e28105. PubMed ID: 22132222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intracellular linkers in gating and desensitization of human pentameric ligand-gated ion channels.
    Papke D; Grosman C
    J Neurosci; 2014 May; 34(21):7238-52. PubMed ID: 24849357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway.
    Shan Q; Han L; Lynch JW
    Br J Pharmacol; 2012 Apr; 165(7):2113-23. PubMed ID: 21955162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neural γ
    Ayan M; Essiz S
    J Mol Model; 2018 Jul; 24(8):206. PubMed ID: 30008086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the structural basis for zinc inhibition of the glycine receptor.
    Nevin ST; Cromer BA; Haddrill JL; Morton CJ; Parker MW; Lynch JW
    J Biol Chem; 2003 Aug; 278(31):28985-92. PubMed ID: 12740384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.
    Baptista-Hon DT; Deeb TZ; Lambert JJ; Peters JA; Hales TG
    J Biol Chem; 2013 Jul; 288(30):21558-68. PubMed ID: 23740249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor.
    Absalom NL; Lewis TM; Kaplan W; Pierce KD; Schofield PR
    J Biol Chem; 2003 Dec; 278(50):50151-7. PubMed ID: 14525990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational changes in extracellular loop 2 associated with signal transduction in the glycine receptor.
    Cederholm JM; Absalom NL; Sugiharto S; Griffith R; Schofield PR; Lewis TM
    J Neurochem; 2010 Dec; 115(5):1245-55. PubMed ID: 20874766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct conformational changes in activated agonist-bound and agonist-free glycine receptor subunits.
    Pless SA; Lynch JW
    J Neurochem; 2009 Mar; 108(6):1585-94. PubMed ID: 19166513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular tuning of fast gating in pentameric ligand-gated ion channels.
    Grutter T; de Carvalho LP; Dufresne V; Taly A; Edelstein SJ; Changeux JP
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18207-12. PubMed ID: 16319224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of charged residues in the intracellular loop on ion permeation in alpha1 glycine receptor channels.
    Carland JE; Cooper MA; Sugiharto S; Jeong HJ; Lewis TM; Barry PH; Peters JA; Lambert JJ; Moorhouse AJ
    J Biol Chem; 2009 Jan; 284(4):2023-30. PubMed ID: 19049967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation.
    Dupre ML; Broyles JM; Mihic SJ
    Brain Res; 2007 Jun; 1152():1-9. PubMed ID: 17434460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate closed state for glycine receptor function revealed by cysteine cross-linking.
    Prevost MS; Moraga-Cid G; Van Renterghem C; Edelstein SJ; Changeux JP; Corringer PJ
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17113-8. PubMed ID: 24085847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed spin labeling reveals pentameric ligand-gated ion channel gating motions.
    Dellisanti CD; Ghosh B; Hanson SM; Raspanti JM; Grant VA; Diarra GM; Schuh AM; Satyshur K; Klug CS; Czajkowski C
    PLoS Biol; 2013 Nov; 11(11):e1001714. PubMed ID: 24260024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.
    Welsh BT; Todorovic J; Kirson D; Allen HM; Bayly MD; Mihic SJ
    Brain Res; 2017 Feb; 1657():148-155. PubMed ID: 27923639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the ρ1 GABA(C) receptor N-terminus in assembly, trafficking and function.
    Wong LW; Tae HS; Cromer BA
    ACS Chem Neurosci; 2014 Dec; 5(12):1266-77. PubMed ID: 25347026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding-site mutations in the alpha1 subunit of the inhibitory glycine receptor convert the inhibitory metal ion Cu2+ into a positive modulator.
    Schumann T; Grudzinska J; Kuzmin D; Betz H; Laube B
    Neuropharmacology; 2009 Jan; 56(1):310-7. PubMed ID: 18793654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site.
    Safar F; Hurdiss E; Erotocritou M; Greiner T; Lape R; Irvine MW; Fang G; Jane D; Yu R; Dämgen MA; Biggin PC; Sivilotti LG
    J Biol Chem; 2017 Mar; 292(12):5031-5042. PubMed ID: 28174298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional complementation of Glra1(spd-ot), a glycine receptor subunit mutant, by independently expressed C-terminal domains.
    Villmann C; Oertel J; Ma-Högemeier ZL; Hollmann M; Sprengel R; Becker K; Breitinger HG; Becker CM
    J Neurosci; 2009 Feb; 29(8):2440-52. PubMed ID: 19244519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.